新华制药：关于会计政策变更的公告

Group 1 - The core point of the article is that Xinhua Pharmaceutical announced a change in accounting policy, which will take effect from January 1, 2026, in accordance with the Ministry of Finance's "Interpretation No. 19 of the Accounting Standards for Enterprises" [1] - The changes involve five aspects, including the recognition of compensatory assets in business combinations under common control and the termination of recognition of financial liabilities related to electronic payment system settlements [1] - The board's decision does not require submission to the shareholders' meeting and will not affect the company's financial position, operating results, or cash flows [1]